Compare Enveric Biosciences Inc (ENVB) vs Global X NASDAQ 100 Covered Call ETF (QYLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Global X NASDAQ 100 Covered Call ETF — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Global X NASDAQ 100 Covered Call ETF trades at $18.16. The key difference: Global X NASDAQ 100 Covered Call ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | QYLD | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $17.40 | $18.52 |
52-Week Low | $1.27 | $16.46 |
Enterprise Value | $1.30M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Global X NASDAQ 100 Covered Call ETF
QYLD is an ETF that follows a covered call strategy on the NASDAQ 100 Index. The fund holds a long position in the stocks of the NASDAQ 100 and simultaneously writes (sells) call options on the index. The primary goal is to generate monthly income from the option premiums. This strategy can reduce portfolio volatility and provide income, but it limits potential capital appreciation from a significant rise in the NASDAQ 100 Index.
Read more on QYLD →
